BindingDB logo
myBDB logout

26 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27994766 28 Discovery of New Bromodomain Scaffolds by Biosensor Fragment Screening.EBI University of Dundee
27682507 167 Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300.EBI Genentech
27673482 4 Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors.EBI Ludwig-Maximilians-Universit£t M£nchen
27190605 77 Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637).EBI Constellation Pharmaceuticals
26982797 20 The"Gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains.EBI University of Z£rich
26572217 60 Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.EBI Genentech
26701186 50 KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.EBI University of Freiburg
26125948 9 Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics.EBI University of Z£rich
26043365 41 Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain.EBI University of Z£rich
26086931 38 Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators.EBI Shandong University
26080064 141 Structure-Based Design of┐-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors.EBI University of Michigan
25730130 20 A novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approach.EBI Universit£ degli Studi di Salerno
25249180 146 The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor.EBI GlaxoSmithKline R&D
24144283 100 Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.EBI Icahn School of Medicine at Mount Sinai
23517011 29 Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.EBI University of Oxford
23095041 16 Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.EBI Pfizer Inc.
21568322 16 Discovery and characterization of small molecule inhibitors of the BET family bromodomains.EBI GlaxoSmithKline R&D
22316554 22 Development of live-cell imaging probes for monitoring histone modifications.EBI Japan Science and Technology Agency
21851057 30 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.EBI University of Oxford
19380225 5 Rapid identification of improved protein ligands using peptoid microarrays.EBI University of Texas Southwestern Medical Center
19138846 23 Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.BDB GSK
16539401 141 Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.BDB Kochi Medical School
16386899 13 Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors.BDB Hawaii Biotech Inc.